Reabilitação cardiovascular em diabéticos tipo 2, pós angioplastia coronariana percutânea

Detalhes bibliográficos
Ano de defesa: 2013
Autor(a) principal: Pilarski, Elisa lattes
Orientador(a): Bettinelli, Luiz Antonio lattes, Pasqualotti, Adriano
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Programa de Pós-Graduação em Envelhecimento Humano
Departamento: Ciências da Saúde e Ciências Biológicas
País: Não Informado pela instituição
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://10.0.217.128:8080/jspui/handle/tede/1120
Resumo: The aim of this study was to evaluate the clinical status of a type 2 diabetic group with heart disease, revascularization by percutaneous coronary angioplasty of a rehabilitation cardiovascular program. A sample consisted of 30 patients, 15 for the control group and 15 in ntervention group, without distinction of sex and just entering the parameter of metabolic syndrome, revascularization, sedentary residents in Chapecó-SC. Physical therapy sessions were held individually 2 times a week totalizing 60 minutes of sitting for a period of 3 months without admission of failure. For statistical analysis and structuring of the database applications Epi Info 3.5.1 and PASW Statistics 18 were used. To analyze the dependency relation between all variables the Mann-Whitney test were used. To analyze the distribution of normality the Kolmogorov-Smirnov test were used. Data were analyzed for significance level of 5% (p &#8804; .05). Intervention group showed significant changes in systolic blood pressure (p = <0.001), diastolic (p = 0.041), oxygen saturation (SaO2) (p = 0.001), heart rate (BPM) (p = 0.429) and glucose (p = <0.001). The assessment of the clinical status of the group that participated in the cardiac rehabilitation program was effective, so the program can be a positive care strategy that should be presented in health systems; it is a cost-effective treatment and has as positive feedback to decrease hospitalization and the appearance of other comorbidities by decreasing exposure to cardiovascular risk factors.